KARLSKOGA, Sweden, Nov. 7, 2025 /PRNewswire/ -- Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen.

Celltrio, a life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, announced the closing of a $15 million financial investment round led by Premier ...

U.S. Cell Therapy Manufacturing Automation Market to Reach USD 4.50 Billion and Europe USD 3.34 Billion by 2035 as CAR-T ...

Traditional robotic cells suit high-volume serial production, while collaborative robot cells are purpose-built for small and mid-sized shops that need faster programming, no safety fencing and the ...

Flexible downstream automation work cells increase the value of molded parts while the parts are still beside the injection molding machine. Maintaining part integrity and orientation through ...

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to ...

The market is projected to surpass $16 billion by 2033, reflecting its rapid transition from research labs into clinical applications such as oncology and prenatal testing. Yet despite this momentum, ...

Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

The report provides gradual automation choices from turnkey inspection cells to customized production workflows ...